TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT
6.1. Overview
6.2. RT PCR Kits
6.3. DFA Kits
6.4. ELISA Kits
6.5. Others
7. GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM
7.1. Overview
7.2. Matrix
7.3. Enterovirus Infection
7.4. Human Coronavirus Infection
7.5. Influenza Virus Infection
7.6. Respiratory Syncytial Virus Infection
7.7. Rhinovirus Infection
7.8. Pneumonia
8. GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY
8.1. Overview
8.2. NAAT (Nucleic Acid Amplification Test)
8.3. Immunoassays
8.4. Others
9. GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER
9.1. Overview
9.2. Hospitals
9.3. Diagnostic Centers
9.4. Specialty Clinics
10. GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Respiratory Pathogen Testing Kits Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Respiratory Pathogen Testing Kits Market,
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2023
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Thermo Fisher Scientific
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Abbott Laboratories
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Danaher Corporation
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Becton, Dickinson and Company
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Hoffmann-La Roche Ltd.
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. BioMérieux Inc.
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Altona Diagnostics
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. MYLAB
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 11 US: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 12 US: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 13 US: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 14 US: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 15 CANADA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 16 CANADA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 17 CANADA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 18 CANADA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 4 EUROPE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 7 GERMANY: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 8 GERMANY: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 FRANCE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 11 FRANCE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 12 FRANCE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 13 ITALY: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 14 ITALY: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 15 ITALY: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 16 ITALY: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 17 SPAIN: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 18 SPAIN: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 19 SPAIN: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 20 SPAIN: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 21 UK: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 22 UK: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 23 UK: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 24 UK: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 25 REST OF EUROPE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 26 REST OF EUROPE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 27 REST OF EUROPE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 28 REST OF EUROPE: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 29 ASIA-PACIFIC: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 30 ASIA-PACIFIC: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 31 ASIA-PACIFIC: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 32 ASIA-PACIFIC: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 33 JAPAN: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 34 JAPAN: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 35 JAPAN: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 36 JAPAN: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 37 CHINA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 38 CHINA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 39 CHINA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 40 CHINA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 41 INDIA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 42 INDIA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 43 INDIA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 44 INDIA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 45 AUSTRALIA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 46 AUSTRALIA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 47 AUSTRALIA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 48 AUSTRALIA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 49 SOUTH KOREA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 50 SOUTH KOREA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 51 SOUTH KOREA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 52 SOUTH KOREA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 53 REST OF ASIA-PACIFIC: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 60 REST OF THE WORLD: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 61 MIDDLE EAST: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 63 MIDDLE EAST: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 64 MIDDLE EAST: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 65 AFRICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 66 AFRICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 67 AFRICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 68 AFRICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 69 LATIN AMERICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 70 LATIN AMERICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY INFECTION/SYMPTOM, 2019-2032 (USD BILLION)
TABLE 71 LATIN AMERICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 72 LATIN AMERICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, BY END-USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET
FIGURE 4 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 5 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, SHARE (%), BY INFECTION/SYMPTOM, 2023
FIGURE 6 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, SHARE (%), BY TECHNOLOGY, 2023
FIGURE 7 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, SHARE (%), BY END-USER, 2023
FIGURE 8 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 NORTH AMERICA: RESPIRATORY PATHOGEN TESTING KITS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 EUROPE: RESPIRATORY PATHOGEN TESTING KITS MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 ASIA-PACIFIC: RESPIRATORY PATHOGEN TESTING KITS MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 REST OF THE WORLD: RESPIRATORY PATHOGEN TESTING KITS MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 GLOBAL RESPIRATORY PATHOGEN TESTING KITS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 14 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS
FIGURE 16 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 18 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 DANAHER CORPORATION: SWOT ANALYSIS
FIGURE 20 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
FIGURE 22 HOFFMANN-LA ROCHE LTD..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 HOFFMANN-LA ROCHE LTD..: SWOT ANALYSIS
FIGURE 24 BIOMÉRIEUX INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BIOMÉRIEUX INC.: SWOT ANALYSIS
FIGURE 26 ALTONA DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ALTONA DIAGNOSTICS: SWOT ANALYSIS
FIGURE 28 MYLAB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 MYLAB: SWOT ANALYSIS
